Connection

Bei Liu to Cell Line, Tumor

This is a "connection" page, showing publications Bei Liu has written about Cell Line, Tumor.
Connection Strength

0.400
  1. Type 2 dendritic cells mediate control of cytotoxic T cell resistant tumors. JCI Insight. 2021 09 08; 6(17).
    View in: PubMed
    Score: 0.137
  2. High expression of endoplasmic reticulum chaperone grp94 is a novel molecular hallmark of malignant plasma cells in multiple myeloma. J Hematol Oncol. 2015 Jun 25; 8:77.
    View in: PubMed
    Score: 0.089
  3. Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma. Clin Cancer Res. 2013 Nov 15; 19(22):6242-51.
    View in: PubMed
    Score: 0.079
  4. Cutting Edge: Targeting Thrombocytes to Rewire Anticancer Immunity in the Tumor Microenvironment and Potentiate Efficacy of PD-1 Blockade. J Immunol. 2019 09 01; 203(5):1105-1110.
    View in: PubMed
    Score: 0.030
  5. Targeting inflammasome/IL-1 pathways for cancer immunotherapy. Sci Rep. 2016 10 27; 6:36107.
    View in: PubMed
    Score: 0.024
  6. Endoplasmic reticulum heat shock protein gp96 maintains liver homeostasis and promotes hepatocellular carcinogenesis. J Hepatol. 2015 Apr; 62(4):879-88.
    View in: PubMed
    Score: 0.021
  7. a7 helix region of aI domain is crucial for integrin binding to endoplasmic reticulum chaperone gp96: a potential therapeutic target for cancer metastasis. J Biol Chem. 2013 Jun 21; 288(25):18243-8.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.